1. Home
  2. CELU vs UG Comparison

CELU vs UG Comparison

Compare CELU & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.24

Market Cap

34.5M

Sector

Health Care

ML Signal

HOLD

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$6.14

Market Cap

27.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CELU
UG
Founded
2016
1942
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
34.5M
27.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CELU
UG
Price
$1.24
$6.14
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
85.8K
11.6K
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
11.29%
EPS Growth
N/A
N/A
EPS
N/A
0.43
Revenue
$40,578,000.00
$10,060,322.00
Revenue This Year
N/A
N/A
Revenue Next Year
$76.00
N/A
P/E Ratio
N/A
$14.53
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$5.58
52 Week High
$4.35
$11.98

Technical Indicators

Market Signals
Indicator
CELU
UG
Relative Strength Index (RSI) 38.58 57.31
Support Level $1.20 $6.08
Resistance Level $1.31 $6.21
Average True Range (ATR) 0.12 0.09
MACD 0.01 0.04
Stochastic Oscillator 52.13 100.00

Price Performance

Historical Comparison
CELU
UG

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: